Generactor's point is important - even clean COVID
Post# of 148292
I bought a small amount of HGEN when they were at 14 (now 3) and CYDY hadn't yet fallen from 4.
Obviously, their molecule is not a major platform like leronlimab. but this shows you that a COVID program with much less hair on it than ours is still getting wiped out.
These guys did everything cleanly - did the reverse split to get on the NASDAQ, raised plenty of money, made stat significance in COVID with far less kludging around than we did, and are accepted enough to present at the JP Morgan health care conference. They get drugs in arms, just filling a 400 person Phase 2/3 hospitalized covid trial. (1)
And the price is $3.14.
As much as I get angry at Nader, it's not all him or the choices CYDY made.
(1) https://finance.yahoo.com/news/humanigen-anno...00996.html